UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001361
Receipt number R000001594
Scientific Title Effects of oral branched chain amino acids (BCAA) supplementation in liver function and QOL after liver resection for hepatocellular carcinoma with liver cirrhosis
Date of disclosure of the study information 2008/09/15
Last modified on 2008/09/09 11:57:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of oral branched chain amino acids (BCAA) supplementation in liver function and QOL after liver resection for hepatocellular carcinoma with liver cirrhosis

Acronym

Effects of oral branched chain amino acids (BCAA) supplementation after liver resection for hepatocellular carcinoma

Scientific Title

Effects of oral branched chain amino acids (BCAA) supplementation in liver function and QOL after liver resection for hepatocellular carcinoma with liver cirrhosis

Scientific Title:Acronym

Effects of oral branched chain amino acids (BCAA) supplementation after liver resection for hepatocellular carcinoma

Region

Japan


Condition

Condition

Hepatocellular carcinoma with liver cirrhosis

Classification by specialty

Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To investigate if oral BCAA supplementation is effective after liver resection for hepatocellular carcinoma with liver cirrhosis.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Liver function and QOL

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Oral branched chain amino acids from 5 day to 28 day after liver resecton

Interventions/Control_2

diet for liver cirrhosis

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

1)Patients planed liver resection for hepatocellular carcinoma with liver cirrhosis
2)no gender
3)Written informed consent for patients or

Key exclusion criteria

1)over 76 years old
2)ICG-R15: 35-40%
3)asites ineffective with a diuretic
4)jaundice
5)liver damage: grade C
6)an allergy to milk
7)renal damage: over Cr 2.0mg/dl
8)primary aminoaciduria
9)pregnant or nursing woman
10)unsutable patients

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masaki Mori

Organization

Graduate School of Medicine, OSAKA University

Division name

Department of Gastroenterological Surgery

Zip code


Address

2-2 Yamadaoka E2, Suita, 565-0871, Osaka

TEL

06-6879-3258

Email



Public contact

Name of contact person

1st name
Middle name
Last name Hiroaki Nagano

Organization

Graduate School of Medicine, OSAKA University

Division name

Department of Gastroenterological Surgery

Zip code


Address

2-2 Yamadaoka E2, Suita, 565-0871, Osaka

TEL

06-6879-3251

Homepage URL


Email



Sponsor or person

Institute

Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2008 Year 09 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Date of protocol fixation

2006 Year 03 Month 01 Day

Date of IRB


Anticipated trial start date

2006 Year 10 Month 01 Day

Last follow-up date

2010 Year 03 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2008 Year 09 Month 09 Day

Last modified on

2008 Year 09 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001594


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name